Clinical Trials Logo

Filter by:
NCT ID: NCT04283578 Completed - Clinical trials for Prader-Willi Syndrome

Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome

OTBB3
Start date: March 10, 2020
Phase: Phase 3
Study type: Interventional

Prospective, randomized, placebo-controlled, double-blind part of the phase III trial to assess the safety and efficacy of 4 weeks oxytocin (OT) administration on oral and social skills in neonates/infants with Prader-Willi Syndrome (PWS) aged less than 3 months at inclusion. Phase III clinical trial.

NCT ID: NCT04282525 Completed - Clinical trials for Extracorporeal Membrane Oxygenation Complication

Monitoring of Cerebral Autoregulation in Pediatric ECMO (ECMOX 1)

ECMOX1
Start date: June 1, 2018
Phase:
Study type: Observational

Children supported by Extra-Corporeal Membrane Oxygenation (ECMO) present a high risk of neurological complications and cerebral autoregulation (CA) impairment may be a risk factor. Our first objective is to investigate the feasibility of CA continuous monitoring during ECMO treatment. The second objective is to analyze the relationship between CA impairment and neurological outcome.

NCT ID: NCT04282512 Completed - Blood Pressure Clinical Trials

Evaluation of the Effect of Sodium Bicarbonate Water on Blood Pressure in Normotensive Subjects

ROX_TENSIO18
Start date: June 28, 2019
Phase: N/A
Study type: Interventional

ROX_TENSIO18 is a randomised cross-over trial and the main objective is to evaluate the effect of daily consumption of sodium bicarbonate water for 15 days on blood pressure. Secondary objective are: - Evaluation of the effect of daily consumption of sodium bicarbonate water on total salt intake - Evaluation on blood pressure of the usual food groups that are the strongest contributors of salt intake.

NCT ID: NCT04282486 Completed - Hemophilia Clinical Trials

Medication Exposure in Older Patients With Constitutional Hemorrhagic Disease

M-HEMORRH'AGE
Start date: July 22, 2020
Phase:
Study type: Observational

The improvements observed in the care of patients with hemophilia or Willebrand disease have led to an increase in their life expectancy, which today approaches that of the general population. This increase in life expectancy leads in these patients to the development of comorbidities related to aging (cardiovascular and neurological diseases, cancers and kidney diseases) (e.g "Franchini & Mannuccio", BJH, 2009). The care of these comorbidities represents a new challenge for the medical teams. Toward multiple comorbidities, polypharmacy is often associated. Many studies about medication exposure and management in older patients were published but no study was conducted to explore the medication management of older patients with hemophilia or Willebrand disease.

NCT ID: NCT04282096 Completed - Protein Digestion Clinical Trials

Nutritional Caracterisation of Micellar Casein

Start date: August 23, 2018
Phase: N/A
Study type: Interventional

There are different types of casein on the market, which differ according to their chemical or physical process of obtaining. The processes will impact structural differences in the macromolecular assembly. The majority of caseins marketed in nutrition are casein in the form of Na caseinate or Ca caseinate. The micellar caseins obtained by membrane filtration (physical process) are more and more used in the nutrition market. The development of casein extraction with different structures on an industrial scale opens up other perspectives for these proteins, particularly in terms of health. The main objective of this project is to study the postprandial kinetics of the plasma concentrations of the essential amino acids of three structurally different types of caseins. The secondary objective is to study the speed of gastric emptying and the nutritional properties of different proteins.

NCT ID: NCT04281472 Completed - Clinical trials for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

ADHERE
Start date: April 15, 2020
Phase: Phase 2
Study type: Interventional

This is a Phase 2 study to evaluate the safety and efficacy of the subcutaneous formulation of efgartigimod in adults with CIDP.

NCT ID: NCT04281212 Completed - Coronary Occlusion Clinical Trials

Observational Study Evaluating the Management of Chronic Coronary Occlusions In France

ENCOCHE
Start date: March 9, 2020
Phase:
Study type: Observational

Data from the literature on the management of Chronic Coronary Occlusions (CTO) in France highlight a lack of epidemiological data on these patients at the national level. For this reason, it was decided to set up this large-scale survey in order to have a picture of the management of patients with chronic coronary occlusion in France, to study the prevalence of CTOs in France as well as their management (medical, surgical or interventional), and then by analysing more precisely, over a second survey period, CTO angioplasties in terms of success rates, complications, medico-economic impact.

NCT ID: NCT04280367 Completed - Schizophrenia Clinical Trials

Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age

DYS FUTURS UHR
Start date: January 28, 2020
Phase:
Study type: Observational

The primary objective of the study aims to study transition toward schizophrenia in patients with learning disorders, and to compare the risk between patients with specific learning disorders, and patients with complexed learning disorders (by two types: patients with other neuro-developmental disorders including executive function disorders, and patients with anxiety).

NCT ID: NCT04279730 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Fatigue and Physical Performance During Pulmonary Rehabilitation

PROMOD
Start date: February 15, 2020
Phase:
Study type: Observational

Patients with COPD benefit from pulmonary rehabilitation (PR), but a ceiling effect of performance (ie. absence of additional exercise tolerance increase) is observed in 80% of patients from only 20 sessions. An imbalance between intensity, duration and frequency of PR sessions, leading to fatigue development in the course of the PR, could explain this ceiling effect. However, previous studies having evaluated the impact of a PR program on fatigue scores reported either a decrease or no changing, but never an increase. To date, no study has evaluated intermediate variations of fatigue score during a PR program, but were limited to a pre-post PR assessment. Therefore, fatigue fluctuations during PR are unknown. Furthermore, most studies had only unidimensional fatigue assessment. Since fatigue is a multifactorial and a multidimensional process, it cannot be accurately estimated through a unique assessment. Given that most of COPD patients do not increase their exercise tolerance from 20 PR sessions, the investigators hypothesize a significant increase of multidimensional fatigue score between the 1st and the 20th PR session during an inpatient rehabilitation program lasting 4 weeks (40 sessions).

NCT ID: NCT04279470 Completed - Cancer Clinical Trials

Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events

CARTABLE
Start date: January 1, 2019
Phase:
Study type: Observational

CAR-T cells and cellular therapies may lead to various adverse reactions. This study investigates reports of different toxicities for cellular therapies in the World Health Organization's (WHO) global database of individual safety case reports (VigiBase).